Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze FRX.TO stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate FRX.TO investment potential.

What is FRX.TO stock price today?

Get real-time FRX.TO stock price, historical data, and price charts on Financhill. Track FRX.TO performance with our advanced analysis tools.

Is FRX.TO a good investment?

Evaluate FRX.TO investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy FRX.TO stock?

To buy FRX.TO stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of FRX.TO?

View detailed market capitalization data and company valuation metrics for FRX.TO on our comprehensive analysis page.

What is the P/E ratio of FRX.TO?

Use our fundamental analysis tools to view FRX.TO P/E ratio and compare valuation metrics with industry peers.

What are FRX.TO earnings?

View FRX.TO earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Fennec Pharmaceuticals, Inc. Stock Predictions

Valuation Up 5,000%. Shares Now $0.85 - Still Early?

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Sell

FRX.TO
Fennec Pharmaceuticals, Inc.

Last Price:

$10.39

Seasonality Move:

17.23%

7 Day Trial

ALL ACCESS PASS

$ 7

Share Price Moved. Momentum Hasn't Slowed.

Fennec Pharmaceuticals, Inc. Stock Forecast

Over the next 52 weeks, Fennec Pharmaceuticals, Inc. has on average historically risen by 14.8% based on the past 24 years of stock performance.
Fennec Pharmaceuticals, Inc. has risen higher in 10 of those 24 years over the subsequent 52-week period, corresponding to a historical accuracy of 41.67%
Is Fennec Pharmaceuticals, Inc. Stock Undervalued?

The current Fennec Pharmaceuticals, Inc. [FRX.TO] share price is $10.39. The Score for FRX.TO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
FRX.TO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Fennec Pharmaceuticals, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Fennec Pharmaceuticals, Inc. has on average historically risen by 14.8% based on the past 24 years of stock performance.

Fennec Pharmaceuticals, Inc. Stock Rating

Sell

Fennec Pharmaceuticals, Inc. (FRX.TO) is a Sell

Is Fennec Pharmaceuticals, Inc. overpriced?

Fennec Pharmaceuticals, Inc. has risen higher in 10 of those 24 years over the subsequent 52-week period, corresponding to a historical accuracy of 41.67%

Fennec Pharmaceuticals, Inc. Stock Price History

Is FRX.TO stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FRX.TO is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

TSX

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

fennecpharma.com

52-Week Data

52-Week High:

13.83

52-Week Low:

7.02

Prediction Charts

Market Cap:

354.9M

Price in USD:

10.39

Volume:

Beta:

0.35

Technical Analysis

SMA50:

11.40

SMA100:

11.77

SMA200:

10.83

52-Wk Change:

27.96%

Stock Predictions

Is Fennec Pharmaceuticals, Inc. stock public?

Yes, Fennec Pharmaceuticals, Inc. is a publicly traded company.
What is the Fennec Pharmaceuticals, Inc. stock quote today?

The Fennec Pharmaceuticals, Inc. stock price is 10.39 USD today.
How to buy Fennec Pharmaceuticals, Inc. stock online?

You can buy Fennec Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Dec-1	11.17	11.17	11.17	11.17
Dec-2	10.70	10.70	10.70	10.70
Dec-3	10.80	10.54	10.80	10.51
Dec-4	10.54	10.54	10.54	10.54
Dec-5	10.54	10.54	10.54	10.54
Dec-8	10.54	10.54	10.54	10.54
Dec-9	10.60	10.60	10.60	10.60
Dec-10	10.60	10.60	10.60	10.60
Dec-11	10.60	10.60	10.60	10.60
Dec-12	10.60	10.60	10.60	10.60
Dec-15	10.60	10.60	10.60	10.60
Dec-16	10.47	10.47	10.47	10.47
Dec-17	10.39	10.39	10.39	10.39
Dec-18	10.39	10.39	10.39	10.39

Fennec Pharmaceuticals, Inc. Earnings

Fennec Pharmaceuticals, Inc. Earnings Report: Per Share Fennec Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Fennec Pharmaceuticals, Inc. Forecast Revenue Growth

Fennec Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Fennec Pharmaceuticals, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.06 per share, and an increase next year of $1.27 per share.

* Fennec Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.